ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Personalis Inc

Personalis Inc (PSNL)

1.66
-0.04
(-2.35%)
Closed July 14 4:00PM
1.68
0.02
(1.20%)
After Hours: 7:45PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.68
Bid
0.70
Ask
3.00
Volume
427,984
1.61 Day's Range 1.79
0.8906 52 Week Range 2.43
Market Cap
Previous Close
1.70
Open
1.70
Last Trade Time
Financial Volume
$ 727,603
VWAP
1.7001
Average Volume (3m)
281,554
Shares Outstanding
51,938,839
Dividend Yield
-
PE Ratio
-0.79
Earnings Per Share (EPS)
-2.09
Revenue
73.48M
Net Profit
-108.3M

About Personalis Inc

Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT... Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Headquarters
Dover, Delaware, USA
Founded
1970
Personalis Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker PSNL. The last closing price for Personalis was $1.70. Over the last year, Personalis shares have traded in a share price range of $ 0.8906 to $ 2.43.

Personalis currently has 51,938,839 shares outstanding. The market capitalization of Personalis is $88.30 million. Personalis has a price to earnings ratio (PE ratio) of -0.79.

PSNL Latest News

Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing

SALT LAKE CITY and FREMONT, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq: MYGN), a leader in genetic testing and precision medicine, and Personalis, Inc. (Nasdaq:...

Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that Chris Hall, CEO and President, will join a panel and speak at the TD Cowen 3rd Annual Tools / Dx...

Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that it has updated the ASCO data highlights conference call to Friday, June 21, 2024 at 8:00 a.m...

ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring

Personalis will host a webinar call on June 19th, 2024 at 1:00 p.m. Pacific Time / 4:00 p.m. Eastern Time to present ASCO highlights from the conference Personalis, Inc. (Nasdaq: PSNL) announced...

Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today the commencement of commercialization efforts by Tempus for NeXT Personal®, Personalis’...

Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that two podium presentations and multiple posters featuring data for the company’s NeXT...

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that the Compensation Committee of its Board of Directors granted, on May 15, 2024, a...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.48401.21.791.29920121.54795136CS
40.3223.52941176471.361.791.1354196811.44097582CS
120.48401.21.851.1352815541.4451014CS
26-0.11-6.145251396651.791.851.123294391.46517263CS
52-0.44-20.75471698112.122.430.89063681421.48449852CS
156-22.31-92.997082117523.9924.10.89064184615.75972278CS
260-23.03-93.201133144524.7153.460.890648039514.20357894CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
$ 9.11
(51.33%)
7.4M
SISIShineco Inc
$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
$ 129.24
(1.44%)
251.65M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
$ 4.25
(25.00%)
167.79M

PSNL Discussion

View Posts
glenn1919 glenn1919 2 months ago
PSNL............................https://stockcharts.com/h-sc/ui?s=PSNL&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 4 months ago
PSNL..................................https://stockcharts.com/h-sc/ui?s=PSNL&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 9 months ago
PSNL new 52=week low
👍️0
ottoman ottoman 9 months ago
Damn, is Cathy dumping? This turd sandwich never taste any better the more I nibble.
👍️0
Monksdream Monksdream 9 months ago
PSNL new 52 week low
👍️0
Invest-in-America Invest-in-America 2 years ago
PSNL: Got some nice REVS/INCOME news late yesterday, Peeps --- could get a little run-up today.
https://pulse2.com/why-the-personalis-stock-increased-over-10-psnl/
👍️0
Timetravelerdos Timetravelerdos 4 years ago
Personalis Announces Delivery of the 100,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program


Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, announced today that it has delivered the 100,000th whole human genome sequence dataset to the U.S. Department of Veterans Affairs Million Veteran Program (VA MVP). Although Personalis has been contracted by the VA MVP since 2012, the program has accelerated and over 50,000 of these genomes have been delivered in 2020.

"The VA MVP is the largest whole genome sequencing project in the United States and this is a significant milestone for both the program and for Personalis," said John West, Chief Executive Officer. "Population-scale sequencing projects of this nature represent a cornerstone in our effort to accelerate the advancement of precision medicine across a wide range of disease areas. With our sizable investments in the technology and infrastructure, necessary to win and execute these projects, Personalis sees population genomics and health as key priorities for our company. We congratulate the VA MVP for their visionary leadership and note that VA scientists now list over 50 peer reviewed publications from the Program."

https://finance.yahoo.com/news/personalis-announces-delivery-100-000th-210700535.html
👍️0
JGrumby JGrumby 5 years ago
Hearing that Monday PSNL will start to get Wall street research reports. Look at PSNL vs GH and NVTA etc
👍️0
JGrumby JGrumby 5 years ago
Nice day after the post IPO sell off.
👍️0

Your Recent History

Delayed Upgrade Clock